‘This Is Not Enough’: Pro-Life Groups Blast FDA over Delayed Abortion Pill Review

The Food and Drug Administration extended the anticipated timeline of its safety review of abortion pills this week, much to pro-lifers’ dismay.

The FDA now says the investigation will continue into next year, according to an update filed in Louisiana federal court late Wednesday night.